Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026

GlobeNewswire

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that it will host a virtual key opinion leader (KOL) event on Monday, September 28, 2026 from 12:30-2:00 PM ET. The event will feature PH-ILD experts Aaron B. Waxman, MD, PhD (Brigham and Women's Hospital) and Paul Yu, MD, PhD (Massachusetts General Hospital), as well as BOS expert Steven Hays, MD (UCSF Health) to discuss the current treatment landscape and unmet need for PH-ILD and BOS as well as the role for LAM-001 as a potential new therapeutic option. To register, click here.

  1. FinanceZentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 AbstractZentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced that overall survival (OS) data from an interim analysis of the DENALI Part 1b study (GOG-3066) have been published in the abstract for the upcoming rapid oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026.
  2. HealthcareEikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology CongressPresentations to cover updates across Eikon’s clinical pipeline including:
  3. Cambria Gold Mines Intersects 98.56 g/t Gold over 8.2 Metres at the Silver Coin Deposit, Premier Gold ProjectCambria Gold Mines Inc. (TSXV: CAMB; OTCQX: CAMVF) (“Cambria” or the “Company”) is pleased to announce new assay results from the ongoing infill drilling program at the Premier Mining Complex (the “Premier Gold Project” or “PGP”), located near Stewart in northwestern British Columbia. Results from four diamond drillholes totalling 657 metres are reported herein. Highlight intervals include:
  4. FinanceDisc Medicine IncDisc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it will host a corporate webcast to discuss topline results from the APOLLO Phase 3 trial of bitopertin in EPP. The webcast will be held on Monday, October 19, 2026 at 8:00 a.m. ET.
  5. INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline, RGRD Law Announces - DOCSThe case alleges Doximity and certain of its top executives made false and/or misleading statement to investors.
  6. QBTS INVESTOR ALERT: D-Wave Quantum Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesThe case alleges that D-Wave and its executives made false and/or misleading statements to investors.